In breast cancer, methylation-mediated silencing of RBP7 activates PPAR and PI3K/AKT signaling, whereas ectopic RBP7 expression suppresses AKT/SREBP1 activity and reduces fatty-acid accumulation in hormone receptor-positive cells [8]. Here, NR4A1 is linked to breast cancer.